Rising sickle cell disease in children demands urgent awareness. Early diagnosis, modern therapies, and vigilant care can ...

The sickle-shaped red blood cells in SCA can cause problems with blood flow, leading to symptoms such as fatigue, pain, jaundice, swelling in your hands and feet, and frequent infections.

Sickle cell anemia is a form of sickle cell disease that occurs when children have fewer healthy red blood cells than expected. ... Treatment: Sickle cell disease. (2019).

These well-known symptoms have inspired innovative research and therapies, such as the recent FDA approval of gene therapies for patients ages 12 years and older with sickle cell disease. However ...

For the study, researchers tracked 2,147 children under age 18 with sickle cell disease treated at least three times between 2010 and 2021 at Children’s Hospital of Atlanta. Of the children, 58% ...

For the kids affected now, Dell Children's started the Sickle Cell Squad in February 2022. ... they have to be hospitalized for treatment, including cleaning out their blood.

In 2019, less than half of children between ages 2 to 16 years with sickle cell anemia got the recommended screening for stroke, one of sickle cell anemia’s most common complications.

“We can put precautions in place that are good for all kids with sickle cell,” Blackwell said. This year’s camp will be held from June 4 to 9, and registration is still available.

Another 31 people had severe sickle cell disease and, on average, had four vaso-occlusive crises a year, in which abnormal red blood cells block the blood supply to tissues. These episodes can ...

Before the 2015 rule change, 41.4% of children with sickle cell disease who made it to Step 3 had their applications approved, according to the SSA data. In the years after the change, the rate ...

Exa-cel provides a potential cure for sickle cell disease in a one-time treatment. The phase 3 clinical trial that led to its approval ( NCT03745287 ) found that exa-cel eliminated vaso-occlusive ...

These well-known symptoms have inspired innovative research and therapies, such as the recent FDA approval of gene therapies for patients ages 12 years and older with sickle cell disease. However ...